Literature DB >> 8768257

Staphylococcus aureus in chronic and recurrent infections.

L Slobodníková1, D Kotulová, I Zahradníková.   

Abstract

Ninety-four Staphylococcus aureus strains isolated from chronic and recurrent skin and respiratory tract infections were investigated for several virulence factor expressions. Production of protein A was noticed in all of the tested strains in amounts from less than 0.1 to more than 2.5 ng per 10(6) bacterial cells. The percentage of the extracellularly produced protein A was found to lie between 4.5 and 27.8%. Two strains (both from the respiratory tract) produced more than 50% of protein A in the extracellular form and one strain did not produce any detectable amount of the extracellular protein A; 99% of the tested strains produced the clumping factor, 96% staphylocoagulase, 79% staphylokinase and 90% gelatinolytic activity; 79% produced alpha-toxin exclusively or in combination with delta- or beta-toxin; 8% of strains produced beta-toxin. There were differences in beta-toxin production between strains from the respiratory tract (5%) and skin infections (25%). delta-Toxin was produced by 53% of the strains. In each of the tested strains a complex of virulence factors was detected. The importance of inactivated extracellular products (especially alpha- and delta-toxin and in the case of skin infections also beta-toxin) as components of staphylococcal whole-cell vaccine was suggested.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8768257     DOI: 10.1007/bf02818525

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  14 in total

Review 1.  Surface-associated activation of plasminogen on gram-positive bacteria. Effect of plasmin on the adherence of Staphylococcus aureus.

Authors:  P Kuusela; M Ullberg; G Kronvall; T Tervo; A Tarkkanen; O Saksela
Journal:  Acta Ophthalmol Suppl       Date:  1992

2.  Distribution of haemolysins in pathogenic and non-pathogenic staphylococci.

Authors:  S D ELEK; E LEVY
Journal:  J Pathol Bacteriol       Date:  1950-10

3.  Effect of protein A on staphylococcal opsonization.

Authors:  P K Peterson; J Verhoef; L D Sabath; P G Quie
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

4.  [Various aspects of the specific immunological effect of staphylococcal vaccine favoring the use of autovaccines. II. Effect of control and immune rabbit sera on staphylococcal growth].

Authors:  S Giedrys-Galant
Journal:  Med Dosw Mikrobiol       Date:  1987

Review 5.  Binding of immunoglobulins to protein A and immunoglobulin levels in mammalian sera.

Authors:  R Lindmark; K Thorén-Tolling; J Sjöquist
Journal:  J Immunol Methods       Date:  1983-08-12       Impact factor: 2.303

6.  Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells.

Authors:  A L Cheung; M Krishnan; E A Jaffe; V A Fischetti
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

7.  Selective immunodeficiency affecting staphylococcal response.

Authors:  M Monteil; J Hobbs; K Citron
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

8.  Human hyperimmune globulin protects against the cytotoxic action of staphylococcal alpha-toxin in vitro and in vivo.

Authors:  S Bhakdi; U Mannhardt; M Muhly; F Hugo; H Ronneberger; K D Hungerer
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

9.  Altered virulence of a pleiotropic Staphylococcus aureus mutant with a low producibility of coagulase and other factors in mice.

Authors:  K Seki; M Ogasawara; J Sakurada; M Murai; S Masuda
Journal:  Microbiol Immunol       Date:  1989       Impact factor: 1.955

10.  Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci.

Authors:  H A Verbrugh; J R Hoidal; B Y Nguyen; J Verhoef; P G Quie; P K Peterson
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

View more
  1 in total

1.  Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus.

Authors:  M E Dominiecki; J Weiss
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.